EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation

Elisa Liberati, H Valerie Curran, Peter Fonagy iD, Henry Clements, Alessandra Lemma, Rosalind McAlpine, David J Nutt, Anne Katrin Schlag, Sunjeev K Kamboj iD

PLOS One · 18.06.2026 · 21 (6) · e0350728

DOI: 10.1371/journal.pone.0350728 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, online erschienen am 18.06.2026. Verfasst von Elisa Liberati und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, London, United Kingd…. Hauptthemen laut MEDLINE: N-Methyl-3,4-methylenedioxyamphetamine, Psychotherapists, Hallucinogens, Stress Disorders, Post-Traumatic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy (MDMA-AP) is a potentially transformative intervention for post-traumatic stress disorder (PTSD). Despite encouraging Phase III trial results, the psychological mechanisms underpinning MDMA’s therapeutic effects remain insufficiently understood. Existing research on MDMA has emphasised neurobiological processes but has not adequately incorporated subjective, relational, and experiential processes that are likely to be central to optimising psychedelic-assisted treatments. In the absence of an established clinical psychological theory of MDMA-AP, qualitative approaches can support theory development to refine and optimise MDMA-AP, and identify cross-diagnostic change processes that may broaden its therapeutic scope. Materials and methods Approximately 25 experienced psychodynamically trained psychotherapists will receive two doses of MDMA (80–120 mg, oral), separated by ≥1 week, under controlled research conditions in an open-label, qualitative mechanistic study. Clinician-participants will complete baseline interviews examining beliefs and attitudes toward MDMA-AP, brief phenomenological interviews during MDMA sessions, in-depth phenomenological and theory-oriented follow-up interviews examining experience and understandings of MDMA-associated change processes, and daily reflective journals between dosing sessions. Additional standardised measures will assess reflective functioning and related constructs. Qualitative data will be analysed using phenomenological and thematic approaches, and grounded theory-inspired techniques will be used to develop a theoretically coherent model of MDMA’s psychological mechanisms of action grounded in the full dataset.

Discussion

In this study of MDMA’s potential mechanisms-of-action, we treat psychotherapists as expert observers of their own psychological processes. By examining first-hand experience in participants selected for their well-developed capacity for self-reflection, meta-awareness, and advanced theoretical and clinical frameworks for understanding mental phenomena, psychopathology, and psychological treatment, we anticipate generating novel insights into MDMA’s therapeutic mechanisms-of-action. The primary study output will be a theoretically grounded model of MDMA’s psychological mechanisms of action, intended to inform novel treatment models amenable to future experimental evaluation. The study also offers a transferable framework for qualitative mechanistic investigations of psychedelic compounds, supporting the development of integrative and evidence-based models of psychedelic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Methyl-3,4-methylenedioxyamphetaminePsychotherapistsHallucinogensStress Disorders, Post-TraumaticPsychoanalytic TherapyHumansQualitative ResearchPsychotherapy

Substanzen

N-Methyl-3,4-methylenedioxyamphetamineHallucinogens

Autor:innen und Institutionen

  • Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, London, United Kingdom.
  • Neuropsychopharmacology Unit, Division of Brain Sciences, Imperial College London, London, United Kingdom.
  • Drug Science, London, United Kingdom.

ORCID-Profile: Peter Fonagy, Sunjeev K Kamboj

Förderung

  • The Memorial Foundation

Zitieren

APA

Liberati, E., Curran, H. V., Fonagy, P., Clements, H., Lemma, A., McAlpine, R., Nutt, D. J., Schlag, A. K., & Kamboj, S. K. (2026). Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation. PLOS One, 21(6), e0350728. https://doi.org/10.1371/journal.pone.0350728

Vancouver

Liberati E, Curran HV, Fonagy P, Clements H, Lemma A, McAlpine R, et al. Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation. PLOS One. 2026;21(6):e0350728. doi:10.1371/journal.pone.0350728

BibTeX
@article{Liberati2026,
  author = {Liberati, Elisa and Curran, H Valerie and Fonagy, Peter and Clements, Henry and Lemma, Alessandra and McAlpine, Rosalind and Nutt, David J and Schlag, Anne Katrin and Kamboj, Sunjeev K},
  title = {Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0350728},
  doi = {10.1371/journal.pone.0350728}
}
Kostenlos starten →